HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Massive Hepatic Necrosis

Extensive and rapid death of parenchymal cells in the LIVER, often due to exposure to toxic materials. It is characterized by a soft, flabby, yellow-brown wrinkled, and shrunken liver. It was called "acute yellow atrophy".
Also Known As:
Acute Yellow Atrophy; Acute Yellow Atrophy of Liver; Acute Yellow Atrophies; Hepatic Necrosis, Massive; Yellow Atrophy, Acute
Networked: 109 relevant articles (3 outcomes, 3 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Hepatitis
2. Liver Cirrhosis (Hepatic Cirrhosis)
3. Protein Deficiency
4. Melanoma (Melanoma, Malignant)
5. Hepatic Encephalopathy

Experts

1. Da Ines, David: 2 articles (05/2013 - 08/2010)
2. Buc, Emmanuel: 2 articles (05/2013 - 08/2010)
3. Chen, Chih-Chiun: 1 article (05/2015)
4. Kim, Ki-Hyun: 1 article (05/2015)
5. Lau, Lester F: 1 article (05/2015)
6. Alpini, Gianfranco: 1 article (05/2015)
7. Dupré, Aurélien: 1 article (05/2013)
8. Tixier, Lucie: 1 article (05/2013)
9. Gagnière, Johan: 1 article (05/2013)
10. Perbet, Sébastien: 1 article (05/2013)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Massive Hepatic Necrosis:
1. Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
2. Proteins (Proteins, Gene)IBA
3. nafamostatIBA
4. TransaminasesIBA
5. Dacarbazine (DIC)FDA LinkGeneric
6. Thromboplastin (Tissue Factor)IBA
7. Prothrombin (Factor II)IBA
8. Lipotropic Agents (Lipotropics)IBA
9. Fibrinogen (Factor I)FDA Link
10. Alkaline PhosphataseIBA

Therapies and Procedures

1. Plasmapheresis
2. Ligation
3. Hepatectomy
4. Drug Therapy (Chemotherapy)
5. Anesthesia